CDC's statement regarding a 2004 Pediatrics Article, "Age at First Measles-Mumps-Rubella Vaccination in Children With Autism and School-matched Control Subjects: A Population-Based Study in Metropolitan Atlanta"
Baram TZ, Gonzalez-Gomez I, Xie ZD, et al. Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis. Ann Neurol 1994;36:103-108.
Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New England Journal of Medicine 2001;345(9):656–661.
Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J 1996;15:88-90.
Bibby AC, Farrell A, Cummins M, Erlewyn-Lajeunesse M. Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura? Arch Dis Child 2008;93:354-355.
Bitnun A, Shannon P, Durward A, et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. [PDF - 703 KB] Clin Infect Dis 1999;29:855-861.
Black S, Shinefield H, Ray P, Lewis E, Chen R, Glasser J, Hadler S, Hardy J, Rhodes P, Swint E, Davis R, Thompson R, Mullooly J, Marcy M, Vadheim C, Ward J, Rastogi S, Wise R. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Infectious Disease Journal 1997;16(5):500–503.
Cooper LZ, Ziring PR, Weiss HJ, Matters BA, Krugman S. Transient arthritis after rubella vaccination. Am J Dis Child 1969;118:218-225.
Davis RL, Kramarz P, Bohlke K, Thompson RS, Mullooly J, Black S, Shinefield H, Ward J, Marcy M, Eriksen E, Lewis N, DeStefano F, Chen R. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the vaccine safety datalink project. Archives of Pediatrics and Adolescent Medicine 2001;155(3):354–359.
DeStefano F, Chen RT. Negative association between MMR and autism. [Commentary] Lancet 1999;353(9169):1987–1988.
Dudgeon JA. Congenital rubella J Pediatr. 1975 Dec;87(6 Pt 2):1078-86.
Dudgeon JA, Marshall WC, Peckham CS. Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines. Am J Dis Child 1969;118:237-243.
France EK, Glanz J, Xu S, et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008;121:e687-692.
Marshall WC, Peckham CS, Darby CP, Dudgeon JA, Hawkins GT. Further studies with rubella vaccines in adults and children. Practitioner 1971;207:632-638.
Miller E, Waight P, Farrington CP, et al. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84:227-229.
Mustafa MM, Weitman SD, Winick NJ, et al. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. [PDF - 959 KB] Clin Infect Dis 1993;16:654-660.
Polk BF, Modlin JF, White JA, DeGirolami PC. A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am J Epidemiol 1982;115:19-25.
Rasmussen, S, Jamieson D. "What Obstetric Health Care Providers Need to Know About Measles and Pregnancy” Journal of Obstetrics & Gynecology Jly 2015: 126(1);163-170. doi: 10.1097/AOG.0000000000000903
Jin J. Measles in the United States. JAMA. Published online February 16, 2015. doi:10.1001/jama.2015.1555.
Zipprich, J. et al. Measles Outbreak- California, December 2014-February 2015. MMWR. Feb. 13, 2015. 64(early release);1-2